(Press-News.org) A research team led by UCLA Health Jonsson Comprehensive Cancer Center investigators has shown that that combining pembrolizumab, an immunotherapy drug, with standard chemotherapy can improve treatment outcomes for patients with small cell bladder cancer and small cell/neuroendocrine prostate cancer.
Small cell carcinomas can arise in various tissues—including the bladder, prostate, lung, ovaries and breast—and are known for their rapid progression, tendency to relapse after initial treatment and poor overall survival rates. The survival time for patients with advanced small cell bladder cancer is only about 7 to 13 months and only 7 to 9 months for patients with small cell/neuroendocrine prostate cancer.
The early-stage study, published in Cell Reports Medicine, showed that using pembrolizumab with chemotherapy resulted in 43% of patients having a partial or complete regression of disease, with 86% of patients with bladder cancer and 57% of those with small cell/neuroendocrine prostate cancer living two years.
“The combination of pembrolizumab and chemotherapy presents a promising new treatment approach for these challenging-to-treat, rare cancers and could be a major breakthrough for patient care,” said Dr. Arnold Chin, professor of urology at the David Geffen School of Medicine at UCLA and senior author of the study.
Immune-based treatment, such as pembrolizumab, has showed success for treating people with a variety of advanced or metastatic cancers, including patients with advanced small cell lung cancer. Previous laboratory-based research at UCLA, led by Dr. Owen Witte, Chin and colleagues, has demonstrated that small cell cancers in the bladder, lung, and prostate share many biological traits. Building on these findings, Chin and his team pursued the concept that treatment approaches should target cancers based on molecular similarities. They designed a clinical trial across all small cell/neuroendocrine urologic cancers combining pembrolizumab and chemotherapy as a first-line therapy for bladder and prostate small cell cancers.
The trial involved 15 patients who were separated into two cohorts. The first included seven participants with advanced or metastatic small cell bladder cancer, while the other group included eight patients with primary small cell or neuroendocrine prostate cancer. The study was designed for patients who would normally receive chemotherapy as part of their standard care.
The researchers found that patients showed favorable responses using this treatment regimen. In bladder cancer group, only one out of seven patients experienced disease progression after a median follow up of almost three years.
For the prostate cancer group, the median survival for patients with small cell/neuroendocrine prostate cancer in the trial reached 27 months, which is longer than expected compared to the historical average of just 7 to 9 months.
The combination treatment was also well-tolerated, with no patients needing to stop therapy due to side effects.
“These results suggests that the combination therapy could provide a substantial survival benefit,” said Chin, who is a member of the UCLA Health Jonsson Comprehensive Cancer Center and the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research.
Along with the encouraging survival rates, the team found that the clonal expansion of CD8+ T cells in the blood, a type of immune cell, in response to treatment correlated with better progression-free survival. This indicated that a blood test could be predictive of treatment response for patients in the future.
The findings support the need for larger clinical trials to confirm these findings.
The study’s first authors are Yiqian Gu, a graduate student in the bioinformatics interdepartmental program at UCLA, and Ann Ly, formerly a staff researcher in the department of urology at UCLA and now a doctoral candidate at UC Davis. UCLA authors include Sara Rodriquez, Hanwei Zhang, Jiyoon Kim, Zhiyuan Mao, Ankush Sachdeva, Nazy Zomorodian, Matteo Pellegrini, Gang Li, Alexandra Drakaki, Matthew Rettig, and Sandy Liu, who is now at City of Hope.
END
Combination approach shows promise for treating rare, aggressive cancers
UCLA research finds that combining immunotherapy with chemotherapy is safe and effective for people with advanced small cell cancers in the bladder and prostate
2024-11-12
ELSE PRESS RELEASES FROM THIS DATE:
Raise the roof: How to reduce badminton birdie drift
2024-11-12
WASHINGTON, Nov. 12, 2024 – Indoor badminton courts are often used for high-stakes tournaments, but even an enclosed court can affect the path of a birdie.
The airflow from a court’s heating, ventilation, and air conditioning (HVAC) system and cross ventilation plays a significant role in badminton. The lightweight feathered birdie passed between the players can be affected by low wind speed in the stadium. This is known as wind drift and has been at the center of multiple tournament controversies. While shutting ...
Ouch! Commonalties found in pain vocalizations and interjections across cultures
2024-11-12
WASHINGTON, Nov. 12, 2024 – There are an estimated 7,000 languages spoken worldwide, each offering unique ways to express human emotion. But do certain emotions show regularities in their vocal expression across languages?
In JASA, published on behalf of the Acoustical Society of America by AIP Publishing, an interdisciplinary team of linguists and bioacousticians led by Maïa Ponsonnet, Katarzyna Pisanski, and Christophe Coupé explored this by comparing expressive interjections (like “wow!”) ...
Income-related disparities in mortality among young adults with type 2 diabetes
2024-11-12
About The Study: In this cohort study of 1.2 million individuals ages 20 to 79 in South Korea, the risk of mortality with low income was most prominent among individuals with type 2 diabetes ages 20 to 39. These findings highlight the need for socioeconomic support to reduce income-related health disparities in younger individuals.
Corresponding authors: To contact the corresponding authors, email Sin Gon Kim, MD, PhD (k50367@korea.ac.kr) and Nam Hoon Kim, MD, PhD (pourlife@korea.ac.kr).
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi: ...
Medical board discipline of physicians for spreading medical misinformation
2024-11-12
About The Study: The frequency of discipline for physician-spread misinformation observed in this cross-sectional study was quite low despite increased salience and medical board warnings since the start of the COVID-19 pandemic about the dangers of physicians spreading falsehoods. These findings suggest a serious disconnect between regulatory guidance and enforcement and call into question the suitability of licensure regulation for combatting physician-spread misinformation.
Corresponding author: To contact the corresponding author, Richard S. Saver, J.D., ...
First-ever randomized clinical trial uses telehealth for suicide prevention
2024-11-12
COLUMBUS, Ohio – Suicide remains a pressing public health concern. An estimated 703,000 people die by suicide each year worldwide, according to The World Health Organization. In 2022, there were 49,449 suicides in the United States.
A new study found that brief cognitive behavioral therapy for suicide prevention – when delivered remotely via video telehealth – reduces suicide attempts and suicidal ideation.
Researchers at The Ohio State University Wexner Medical Center and College of Medicine led the study that is published online in the journal JAMA Network Open.
The randomized clinical ...
DNA packaging directly affects how fast DNA is copied in cells
2024-11-12
Researchers from the Mattiroli group have found that the way DNA is packaged in cells can directly impact how fast DNA itself is copied during cell division. They discovered that DNA packaging sends signals through an unusual pathway, affecting the cell’s ability to divide and grow. This opens up new doors to study how the copying of the DNA and its packaging are linked. These findings, published in Molecular Cell, may help scientists to find therapies and medicines for diseases such as cancer in the future.
Chromatin as a guide
Every day, our cells divide. Each time they need to copy both their DNA and the structure in which the DNA is packed. This packaging, ...
Scientists develop advanced catalyst for self-driven seawater splitting with enhanced chloride resistance
2024-11-12
Seawater electrolysis has long been seen as a promising pathway for sustainable hydrogen production but has faced significant limitations due to chloride ion (Cl⁻) corrosion, which can degrade a catalyst's performance.
Now scientists from the Qingdao Institute of Bioenergy and Bioprocess Technology (QIBEBT) of the Chinese Academy of Sciences, along with their collaborators, have developed an efficient electrocatalyst called Co-N/S-HCS that demonstrates remarkable activity and stability in ...
City of Hope researchers discover why taking a mushroom supplement slows or prevents prostate cancer from getting worse
2024-11-12
LOS ANGELES — Researchers at City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the United States, ranked among the nation’s top 5 cancer centers by U.S. News & World Report and a national leader in providing cancer patients with best-in-class, integrated supportive care programs, now understand why taking an investigational white button mushroom supplement shows promise in slowing and even preventing prostate cancer from spreading among men who joined ...
Montefiore Einstein’s Marina Konopleva joins Break Through Cancer TeamLab in fight against acute myelogenous leukemia
2024-11-12
November 12, 2024—(BRONX, NY)— Marina Konopleva, M.D., Ph.D., director of the Leukemia Program and co-director of the Blood Cancer Institute at the National Cancer Institute-designated Montefiore Einstein Comprehensive Cancer Center (MECCC), has joined forces with Break Through Cancer, a collaborative medical research foundation that supports teams of scientists as they advance treatments for some of the world’s deadliest cancers. Dr. Konopleva will play a pivotal role in the Eradicating Minimal Residual Disease (MRD) in Acute ...
Early treatment for nerve tumors prevents serious problems, study finds
2024-11-12
Patients with a small cranial nerve tumor that can cause hearing loss, vertigo, imbalance and ringing in the ears have typically been watched rather than proactively treated, as the risks of early intervention were thought to outweigh the benefits. However, even those patients benefit significantly from non-invasive stereotactic radiosurgery, a multicenter, international study led by UVA Health physicians has found.
Doctors typically treat larger forms of the tumors, called vestibular schwannomas, while taking a “watch and wait” approach ...
LAST 30 PRESS RELEASES:
Reality check: making indoor smartphone-based augmented reality work
Overthinking what you said? It’s your ‘lizard brain’ talking to newer, advanced parts of your brain
Black men — including transit workers — are targets for aggression on public transportation, study shows
Troubling spike in severe pregnancy-related complications for all ages in Illinois
Alcohol use identified by UTHealth Houston researchers as most common predictor of escalated cannabis vaping among youths in Texas
Need a landing pad for helicopter parenting? Frame tasks as learning
New MUSC Hollings Cancer Center research shows how Golgi stress affects T-cells' tumor-fighting ability
#16to365: New resources for year-round activism to end gender-based violence and strengthen bodily autonomy for all
Earliest fish-trapping facility in Central America discovered in Maya lowlands
São Paulo to host School on Disordered Systems
New insights into sleep uncover key mechanisms related to cognitive function
USC announces strategic collaboration with Autobahn Labs to accelerate drug discovery
Detroit health professionals urge the community to act and address the dangers of antimicrobial resistance
3D-printing advance mitigates three defects simultaneously for failure-free metal parts
Ancient hot water on Mars points to habitable past: Curtin study
In Patagonia, more snow could protect glaciers from melt — but only if we curb greenhouse gas emissions soon
Simplicity is key to understanding and achieving goals
Caste differentiation in ants
Nutrition that aligns with guidelines during pregnancy may be associated with better infant growth outcomes, NIH study finds
New technology points to unexpected uses for snoRNA
Racial and ethnic variation in survival in early-onset colorectal cancer
Disparities by race and urbanicity in online health care facility reviews
Exploring factors affecting workers' acquisition of exercise habits using machine learning approaches
Nano-patterned copper oxide sensor for ultra-low hydrogen detection
Maintaining bridge safer; Digital sensing-based monitoring system
A novel approach for the composition design of high-entropy fluorite oxides with low thermal conductivity
A groundbreaking new approach to treating chronic abdominal pain
ECOG-ACRIN appoints seven researchers to scientific committee leadership positions
New model of neuronal circuit provides insight on eye movement
Cooking up a breakthrough: Penn engineers refine lipid nanoparticles for better mRNA therapies
[Press-News.org] Combination approach shows promise for treating rare, aggressive cancersUCLA research finds that combining immunotherapy with chemotherapy is safe and effective for people with advanced small cell cancers in the bladder and prostate